Selected research
Industry Research
Glucokinase Industry Research Report 2026
Market perspective
The global Glucokinase market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glucokinase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glucokinase is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glucokinase is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glucokinase include Amgen Inc, Eli Lilly and Co, Ligand Pharmaceuticals Inc, Merck & Co Inc, Poxel SA, Teijin Pharma Ltd, vTv Therapeutics Inc and Yuhan Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glucokinase market in terms of revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glucokinase Market by Company
Amgen Inc
Eli Lilly and Co
Ligand Pharmaceuticals Inc
Merck & Co Inc
Poxel SA
Teijin Pharma Ltd
vTv Therapeutics Inc
Yuhan Corp
Glucokinase Segment by Type
LY-2608204
Sinogliatin
AM-9514
TMG-123
TTP-399
Others
Glucokinase Segment by Application
Metabolic Disorder
Obesity
Diabetes
Others
Glucokinase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucokinase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glucokinase manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glucokinase by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glucokinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- LY-2608204
- Sinogliatin
- AM-9514
- TMG-123
- TTP-399
- Others
Applications
- Metabolic Disorder
- Obesity
- Diabetes
- Others
Companies covered
- Amgen Inc
- Eli Lilly and Co
- Ligand Pharmaceuticals Inc
- Merck & Co Inc
- Poxel SA
- Teijin Pharma Ltd
- vTv Therapeutics Inc
- Yuhan Corp
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glucokinase Market Size (2021-2032)
- 2.2.2 Global Glucokinase Sales (2021-2032)
- 2.2.3 Global Glucokinase Market Average Price (2021-2032)
- 2.3 Glucokinase by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 LY-2608204
- 2.3.3 Sinogliatin
- 2.3.4 AM-9514
- 2.3.5 TMG-123
- 2.3.6 TTP-399
- 2.3.7 Others
- 2.4 Glucokinase by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Metabolic Disorder
- 2.4.3 Obesity
- 2.4.4 Diabetes
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glucokinase Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glucokinase Sales (kt) of Manufacturers (2021-2026)
- 3.3 Global Glucokinase Revenue of Manufacturers (2021-2026)
- 3.4 Global Glucokinase Average Price by Manufacturers (2021-2026)
- 3.5 Global Glucokinase Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glucokinase, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glucokinase, Product Type & Application
- 3.8 Global Manufacturers of Glucokinase, Established Date
- 3.9 Global Glucokinase Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Amgen Inc
- 4.1.1 Amgen Inc Company Information
- 4.1.2 Amgen Inc Business Overview
- 4.1.3 Amgen Inc Glucokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Amgen Inc Glucokinase Product Portfolio
- 4.1.5 Amgen Inc Recent Developments
- 4.2 Eli Lilly and Co
- 4.2.1 Eli Lilly and Co Company Information
- 4.2.2 Eli Lilly and Co Business Overview
- 4.2.3 Eli Lilly and Co Glucokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly and Co Glucokinase Product Portfolio
- 4.2.5 Eli Lilly and Co Recent Developments
- 4.3 Ligand Pharmaceuticals Inc
- 4.3.1 Ligand Pharmaceuticals Inc Company Information
- 4.3.2 Ligand Pharmaceuticals Inc Business Overview
- 4.3.3 Ligand Pharmaceuticals Inc Glucokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ligand Pharmaceuticals Inc Glucokinase Product Portfolio
- 4.3.5 Ligand Pharmaceuticals Inc Recent Developments
- 4.4 Merck & Co Inc
- 4.4.1 Merck & Co Inc Company Information
- 4.4.2 Merck & Co Inc Business Overview
- 4.4.3 Merck & Co Inc Glucokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck & Co Inc Glucokinase Product Portfolio
- 4.4.5 Merck & Co Inc Recent Developments
- 4.5 Poxel SA
- 4.5.1 Poxel SA Company Information
- 4.5.2 Poxel SA Business Overview
- 4.5.3 Poxel SA Glucokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Poxel SA Glucokinase Product Portfolio
- 4.5.5 Poxel SA Recent Developments
- 4.6 Teijin Pharma Ltd
- 4.6.1 Teijin Pharma Ltd Company Information
- 4.6.2 Teijin Pharma Ltd Business Overview
- 4.6.3 Teijin Pharma Ltd Glucokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Teijin Pharma Ltd Glucokinase Product Portfolio
- 4.6.5 Teijin Pharma Ltd Recent Developments
- 4.7 vTv Therapeutics Inc
- 4.7.1 vTv Therapeutics Inc Company Information
- 4.7.2 vTv Therapeutics Inc Business Overview
- 4.7.3 vTv Therapeutics Inc Glucokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 vTv Therapeutics Inc Glucokinase Product Portfolio
- 4.7.5 vTv Therapeutics Inc Recent Developments
- 4.8 Yuhan Corp
- 4.8.1 Yuhan Corp Company Information
- 4.8.2 Yuhan Corp Business Overview
- 4.8.3 Yuhan Corp Glucokinase Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Yuhan Corp Glucokinase Product Portfolio
- 4.8.5 Yuhan Corp Recent Developments
5 Global Glucokinase Market Scenario by Region
- 5.1 Global Glucokinase Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glucokinase Sales by Region: 2021-2032
- 5.2.1 Global Glucokinase Sales by Region: 2021-2026
- 5.2.2 Global Glucokinase Sales by Region: 2027-2032
- 5.3 Global Glucokinase Revenue by Region: 2021-2032
- 5.3.1 Global Glucokinase Revenue by Region: 2021-2026
- 5.3.2 Global Glucokinase Revenue by Region: 2027-2032
- 5.4 North America Glucokinase Market Facts & Figures by Country
- 5.4.1 North America Glucokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glucokinase Sales by Country (2021-2032)
- 5.4.3 North America Glucokinase Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glucokinase Market Facts & Figures by Country
- 5.5.1 Europe Glucokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glucokinase Sales by Country (2021-2032)
- 5.5.3 Europe Glucokinase Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glucokinase Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glucokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glucokinase Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glucokinase Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glucokinase Market Facts & Figures by Country
- 5.7.1 South America Glucokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glucokinase Sales by Country (2021-2032)
- 5.7.3 South America Glucokinase Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glucokinase Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glucokinase Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glucokinase Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glucokinase Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glucokinase Sales by Type (2021-2032)
- 6.1.1 Global Glucokinase Sales by Type (2021-2032) & (kt)
- 6.1.2 Global Glucokinase Sales Market Share by Type (2021-2032)
- 6.2 Global Glucokinase Revenue by Type (2021-2032)
- 6.2.1 Global Glucokinase Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glucokinase Revenue Market Share by Type (2021-2032)
- 6.3 Global Glucokinase Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glucokinase Sales by Application (2021-2032)
- 7.1.1 Global Glucokinase Sales by Application (2021-2032) & (kt)
- 7.1.2 Global Glucokinase Sales Market Share by Application (2021-2032)
- 7.2 Global Glucokinase Revenue by Application (2021-2032)
- 7.2.1 Global Glucokinase Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glucokinase Revenue Market Share by Application (2021-2032)
- 7.3 Global Glucokinase Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glucokinase Value Chain Analysis
- 8.1.1 Glucokinase Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glucokinase Production Mode & Process
- 8.2 Glucokinase Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glucokinase Distributors
- 8.2.3 Glucokinase Customers
9 Global Glucokinase Analyzing Market Dynamics
- 9.1 Glucokinase Industry Trends
- 9.2 Glucokinase Industry Drivers
- 9.3 Glucokinase Industry Opportunities and Challenges
- 9.4 Glucokinase Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst